Direxion Daily S&P Biotech Bear 3X Shares
LABD
LABD
17 hedge funds and large institutions have $18.1M invested in Direxion Daily S&P Biotech Bear 3X Shares in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
19% less funds holding
Funds holding: 21 → 17 (-4)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Holders
17
Holding in Top 10
–
Calls
$7.1M
Puts
$1.81M
Top Buyers
| 1 | +$3.98M | |
| 2 | +$3.28M | |
| 3 | +$894K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$785K |
| 5 |
Jane Street
New York
|
+$396K |
Top Sellers
| 1 | -$4.02M | |
| 2 | -$3.57M | |
| 3 | -$2.55M | |
| 4 |
ASM
AI-Squared Management
Hong Kong
|
-$1.38M |
| 5 |
Squarepoint
New York
|
-$733K |